| Phase 1/2 | 1 | |
| Phase 2/3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT03913143 | A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of… | Leber Congenital Amaurosis 10 | Active, Not Recruiting | 2022-03-17 |
| Phase 1/2 | ||||
| NCT04123626 | A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal… | Autosomal Dominant Retinitis Pigmentosa | Active, Not Recruiting | 2022-05-06 |